There are five different tumor necrosis factor (TNF) inhibitors available for the treatment of RA. Researchers say that despite showing similar efficacy, they differ in molecular structures and signaling disruption.
The FDA this week announced approval of Maci, “matrix-induced autologous chondrocyte implantation.” The treatment is intended for cartilage defects of the knee, which can eventually lead to osteoarthritis.
Johns Hopkins researchers have linked a specific bacteria involved in gum disease to the processes at hand in rheumatoid arthritis. It may be premature, however, to consider flossing an aspect of joint health.